Immunotherapy for Breast Cancer: Part 2

Immunotherapy for Breast Cancer: Part 2

Jennifer Litton, MD, talks about how immunotherapy medicines work and how they are being researched for breast cancer.
Apr 26, 2018
/_next/static/media/art.743baba8.png
00:00
Download
00:00

Listen to the podcast to hear Dr. Litton discuss:

  • how immunotherapy medicines work

  • why immunotherapy medicines haven’t seemed to work as well in breast cancer as they have in other cancers

  • the direction of immunotherapy research for breast cancer

About the guest
 
Jennifer Litton headshot
Jennifer Litton, MD

Dr. Jennifer Litton is a board-certified medical oncologist and professor of breast medical oncology at the University of Texas MD Anderson Cancer Center in Houston, where she is also vice president of clinical research. She also is a member of the Breast Immuno-Oncology Task Force of the National Cancer Institute.

— Last updated on July 31, 2022, 10:20 PM

 
 
Support Breastcancer.org to produce more content like this

Your donation goes directly to what you read, hear, and see on Breastcancer.org.

Donate